Gilead Sciences, Inc.GILDNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank79
3Y CAGR+22.8%
5Y CAGR+133.3%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
+22.8%/yr
vs -4.2%/yr prior
5Y CAGR
+133.3%/yr
Recent deceleration
Acceleration
+27.0pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
69.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.51B | +1672.9% |
| 2024 | $480.00M | -91.5% |
| 2023 | $5.67B | +23.4% |
| 2022 | $4.59B | -26.2% |
| 2021 | $6.22B | +4961.0% |
| 2020 | $123.00M | -97.7% |
| 2019 | $5.39B | -1.3% |
| 2018 | $5.46B | +17.9% |
| 2017 | $4.63B | -65.7% |
| 2016 | $13.50B | - |